Atlas Trials

Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza

Clinical trial NCT05095545 · COMPLETED

Trial details

NCT number
NCT05095545
Sponsor
Viriom
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Influenza
Start date
2017-11-13
Primary completion
2019-08-07
Enrollment
135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.